{"name":"Moberg Pharma AB","slug":"moberg-pharma-ab","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"immunology","drugs":[{"name":"K40a","genericName":"K40a","slug":"k40a","indication":"Other","status":"phase_2"},{"name":"K40b","genericName":"K40b","slug":"k40b","indication":"Other","status":"phase_2"},{"name":"MOB015","genericName":"MOB015","slug":"mob015","indication":"Other","status":"phase_2"},{"name":"MOB015B vehicle","genericName":"MOB015B vehicle","slug":"mob015b-vehicle","indication":"Topical drug delivery enhancement (specific indication dependent on active ingredient)","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"K301","genericName":"K301","slug":"k301","indication":"Onychomycosis (fungal nail infection)","status":"phase_3"},{"name":"MOB015B","genericName":"MOB015B","slug":"mob015b","indication":"Onychomycosis (fungal nail infection)","status":"phase_3"}]}],"pipeline":[{"name":"K301","genericName":"K301","slug":"k301","phase":"phase_3","mechanism":"K301 is a topical antimicrobial agent designed to treat fungal nail infections by inhibiting fungal growth and promoting nail healing.","indications":["Onychomycosis (fungal nail infection)"],"catalyst":""},{"name":"K40a","genericName":"K40a","slug":"k40a","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"K40b","genericName":"K40b","slug":"k40b","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MOB015","genericName":"MOB015","slug":"mob015","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"MOB015B","genericName":"MOB015B","slug":"mob015b","phase":"phase_3","mechanism":"MOB015B is a topical antimicrobial agent designed to treat fungal nail infections by inhibiting fungal growth and promoting nail clearance.","indications":["Onychomycosis (fungal nail infection)"],"catalyst":""},{"name":"MOB015B vehicle","genericName":"MOB015B vehicle","slug":"mob015b-vehicle","phase":"phase_3","mechanism":"MOB015B is a topical vehicle formulation designed to enhance drug delivery and penetration through the skin barrier.","indications":["Topical drug delivery enhancement (specific indication dependent on active ingredient)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPd216VVA4Q1ZMTVBCVS1CWEs4aEIxNkxITmRSZTYyOXNKS2p0TTFPTUtrRElBdmRmMG5VaEs5Y3Z2WFp5c1hzMVVTLUdkTXJRdGNvcHI0eTlzY1ZNZnlubUhIdWE1dXVZWlF5WXBGTWI2Um9xcUk2Vmd0NGhrWXpZd3ppaXh5WDJMV0hVZWdEbVFFUXBnUjRkX0phWGIxeVFFY2xSaTltQ1c?oc=5","date":"2026-04-03","type":"pipeline","source":"TradingView","summary":"Free cash flow per share of Moberg Pharma AB – LSX:A3EGXK - TradingView","headline":"Free cash flow per share of Moberg Pharma AB – LSX:A3EGXK","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQUzRkWUl6ZmRaU19FbTFMVnN4cjNteHdRU0E0WnI5TUlRc2tmTGxUdnhNbXVYdlNyT1l5YXdIem1NdWZKQUpNMVNuM2lxbFRTMURUQlJHSWNlb0JGWUszd21DSVc0ZkY4T0Y1R2xKY2hEQ1RqOFU5SDRUSUhkTFNLbURwTUpwaV9WU240Tmdxa0xXMW5xMWh0STRTdGJGSXdfYmtsUUgza1hLZjdUVWc?oc=5","date":"2026-03-13","type":"pipeline","source":"seekingalpha.com","summary":"Moberg Pharma AB (publ) (MBGPF) Presents at Stora Aktiedagarna - Slideshow (OTCMKTS:MBGPF) 2026-03-13 - seekingalpha.com","headline":"Moberg Pharma AB (publ) (MBGPF) Presents at Stora Aktiedagarna - Slideshow (OTCMKTS:MBGPF) 2026-03-13","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOMDRIa3ZRbjdILWRPT082U3NVWEx4Uzh6UmhYSGZLaWFBZi1yUmxYcW9QdENGZnpWQTNQcEFGeGJrRnJCcVJyWXBpT2hHWXZ3NGs2NnA4YndiZVRMNWpScVMxZGxmbWNlT0wydDl2OUluV1ZEeExYRHhrT0RfMi1TOGtwZEg0VHFkV0ZiVFRxb2pTMmp0Z3ktLWo2cGpwYlJGeFZneFJhRDRoUDMySnNwN1dKTDgxWUs5TGJvNFRkVHZXcmdJQWc?oc=5","date":"2026-03-13","type":"pipeline","source":"TipRanks","summary":"Moberg Pharma Secures Second Terbinafine Supplier for Lead Nail Fungus Drug - TipRanks","headline":"Moberg Pharma Secures Second Terbinafine Supplier for Lead Nail Fungus Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxPaFFIUWVieFNTbnJzMGp4T2VlODBndHdvcWtkemtOR3h2SXJjSkQxcC1PZ2ozZmZPa25mWl9tMnFnT0MxV3M4TnFyZ2lTYU1UOU9pczJOOFlvSzhlUF9ta3REUXp6RVVMMGFRV2RJa3lpTnRJREFHYmVZYUM2UjNqWXhNNTYtZV9vdV9mdTNxejFQY0xuS3YyNmo4dGxtN3g1bWxRQ2I5LVczUV9ELVMza21TVTdNcC1ONkREOA?oc=5","date":"2026-02-16","type":"deal","source":"TipRanks","summary":"Moberg Pharma Secures Lamisil Deal as Terclara Gains Nordic Momentum - TipRanks","headline":"Moberg Pharma Secures Lamisil Deal as Terclara Gains Nordic Momentum","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNSnlDNTRveE9pSXp6b3RORno4RVlvS3JwbEU4Rk9OVmZXOVhNWS1RWXJfY2drN20wSVBSSDdCR0J5UDFJVU42djhZZkRheE10TTVjWWtJM2lrbkJuaXN4UmlUWXBwdE5VX1JuQmMyVGREUUFWa0J5ZWExWFB6OFpIVFZhWGhmMmM0?oc=5","date":"2025-11-05","type":"deal","source":"Yahoo Finance","summary":"Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding access and growth potential - Yahoo Finance","headline":"Moberg Pharma and Karo Healthcare enter into an exclusive license agreement for MOB-015/Terclara in Europe, expanding ac","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxQUnc3cVlsWE45cXduTHlkNTlUeU9TTVA0RFBSM1BVbFZ5cFRQREMza0FPX2NfaWgyNVd1ckpwUUhZcDJYMlJNeHZSZGtBRzJHVmZRZndDTkJ3SnpkX3NvSm02SjFEV1RHZWlzRzZaajhkWmhFcDhFN0JrY2JYZ2xMajhvUzQwSkpXdGZEajd5VQ?oc=5","date":"2025-11-04","type":"deal","source":"Yahoo Finance","summary":"Karo Healthcare enters an exclusive license agreement with Moberg Pharma for MOB-015 in Europe - Yahoo Finance","headline":"Karo Healthcare enters an exclusive license agreement with Moberg Pharma for MOB-015 in Europe","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5rb2pqQnlnU0hST1Yxa1ZvSUtURVFHeV9saXdJOTl6THg3enZFUHJ5d29pR0NVR0FRMWp1NU16dS02b1c3cnh2a240R3daZHNsM3o2RUxQQlpqcndoOEFzODBWSkxJRUU?oc=5","date":"2025-08-07","type":"pipeline","source":"Market.us","summary":"Onychomycosis Treatment Market Size, Share | CAGR Of 4.4% - Market.us","headline":"Onychomycosis Treatment Market Size, Share | CAGR Of 4.4%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxOUlNUdWYxT2YxYzdoeFFIbkxZYm5UcVNUUEF4WVVDb2lrZlhnT1pHZUNvclpBYkliaFdjR0lOQ3NnQXppckg5amZsTU4tNzY2QXd6bjIxRFhLYk4tdzAwLVJGMmtlbmk5ZlkyNXUwSjhlVFIwMVdEaEdMZGdzeGVKamNUdFdGeHBBTEdKR2FNd0ZLMURLRWc?oc=5","date":"2024-11-18","type":"deal","source":"seekingalpha.com","summary":"Consider Buying Moberg Pharma Ahead Of Drug Launch (OTCMKTS:MBGPF) - seekingalpha.com","headline":"Consider Buying Moberg Pharma Ahead Of Drug Launch (OTCMKTS:MBGPF)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE4zQ2gtQzdJNml5RE1iSTZZblNNY1ZrVno3UTczTVV3eHpGdTUwcUNGZVpCaFRoZkRCTzZBMGNMOTVPMi1zdnlBQ2U1ci1DYmgyS3p3d0hYQlV1d2RsbS1QLWdyeXF6d0V3ZjB2NDNZZmJ3UjVZeHc?oc=5","date":"2024-02-08","type":"pipeline","source":"Cision News","summary":"Terclara Setup2 2312 - Cision News","headline":"Terclara Setup2 2312","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxOa25Ed2tQYVBxLUpmY3NJWVNNRU5YQkJXTmRvekpKakNGanFOQUk4Tk5pc2NVRURQVWtsVVZzdjRQNEkxX2xfMnVELWphXzhsOEhhTkN0SHIzeWJrUU5vMGt1U2hwVkM3dGJ1aHhZSXBaeUxHOU91a2hIa19TUTFiX0owdW5MZmlNeDlqaWxzWklIN0lKWmhLMEwtbTM5UncwUmd3QWNLOHdlVUEza3pSWlhCYWJVLW5HTUlKYXkyYjhONGFYVF9oMDFmUEZaNENjdW9KVTdyZXc0MkVNZ2R3NzBmYlRqNjB1NEJTM1EyYXNNX2M?oc=5","date":"2017-04-27","type":"pipeline","source":"BioSpace","summary":"Moberg Pharma AB (Formerly known as Moberg Derma) Receives $3 Million To Expand Its Focus On Precision Management Of Brain Injured Patients - BioSpace","headline":"Moberg Pharma AB (Formerly known as Moberg Derma) Receives $3 Million To Expand Its Focus On Precision Management Of Bra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNYTRLRXY3VFNaNE1HaEdjTGxDR1JKdDU0c2JnSFU4bXZCclAyOXdFX256NDUzUWNZZkVYSHFhVHdEeU9GRTZ5RFZ2QS1rd2dyNVl1bUtwNmZncGhDdnFkQkRaaEZrTHA0YVE5TE1tVmhSNTFYSnVKaGhPMW5qSGVVVE1paFRXc3lLSVNOWVRtaXg0dw?oc=5","date":"2016-08-01","type":"deal","source":"Happi | Household And Personal Products Industry","summary":"Moberg Pharma AB Buys New Skin from Prestige Brands - Happi | Household And Personal Products Industry","headline":"Moberg Pharma AB Buys New Skin from Prestige Brands - Happi | Household And Personal Products Industry","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQUFlBcmtXX2I0NWVYOUVlcXlScHZlWnp6OW0yS3ZrN2JNVmNISlZlU1pVUkFnY3p5UFdUWEJqWEFSVjMwcFhWOFJ1T01uYklfcVlfM3lHWnRNVHU3MkdDZGQ1SkNpLUx0ZWx5bzF1UVZGanNRT3ZyYU9YZ3ZXbDljN0E1VWlHVU5SeDVNQw?oc=5","date":"2014-11-04","type":"deal","source":"Drug Store News","summary":"Moberg Pharma announces partnership with Emerson Group - Drug Store News","headline":"Moberg Pharma announces partnership with Emerson Group","sentiment":"neutral"}],"patents":[],"drugCount":6,"phaseCounts":{"phase_3":3,"phase_2":3},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}